Wei-jian Ni

No. 17 Lujiang Road
Hefei, 230001, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

The m7G methyltransferase METTL1 promotes acute kidney inflammation by disrupting mitochondrial function.

The m7G methyltransferase METTL1 promotes acute kidney inflammation by disrupting mitochondrial function.

Journal: Kidney international

Published: May 26, 2025

Aurantiamide mitigates acute kidney injury by suppressing renal necroptosis and inflammation via GRPR-dependent mechanism.

Aurantiamide mitigates acute kidney injury by suppressing renal necroptosis and inflammation via GRPR-dependent mechanism.

Journal: International immunopharmacology

Published: April 15, 2024

Genetic and pharmacological inhibition of METTL3 alleviates renal fibrosis by reducing EVL m6A modification through an IGF2BP2-dependent mechanism.

Genetic and pharmacological inhibition of METTL3 alleviates renal fibrosis by reducing EVL m6A modification through an IGF2BP2-dependent mechanism.

Journal: Clinical and translational medicine

Published: April 03, 2023

Targeted modulation of gut microbiota by traditional Chinese medicine and natural products for liver disease therapy.

Targeted modulation of gut microbiota by traditional Chinese medicine and natural products for liver disease therapy.

Journal: Frontiers in immunology

Published: November 01, 2022

Effect of CX3CL1/CX3CR1 gene polymorphisms on the clinical efficacy of carboplatin therapy in Han patients with ovarian cancer.

Effect of CX3CL1/CX3CR1 gene polymorphisms on the clinical efficacy of carboplatin therapy in Han patients with ovarian cancer.

Journal: Frontiers in genetics

Published: October 09, 2022

Highly pathogenic coronaviruses and the kidney.

Highly pathogenic coronaviruses and the kidney.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: August 16, 2022

RIPK3 inhibitor-AZD5423 alleviates acute kidney injury by inhibiting necroptosis and inflammation.

RIPK3 inhibitor-AZD5423 alleviates acute kidney injury by inhibiting necroptosis and inflammation.

Journal: International immunopharmacology

Published: July 20, 2022

Cpd-0225 attenuates renal fibrosis via inhibiting ALK5.

Cpd-0225 attenuates renal fibrosis via inhibiting ALK5.

Journal: Biochemical pharmacology

Published: July 18, 2022

Role of epigenetically regulated inflammation in renal diseases.

Role of epigenetically regulated inflammation in renal diseases.

Journal: Seminars in cell & developmental biology

Published: July 15, 2022

RNA N6 -methyladenosine modifications and potential targeted therapeutic strategies in kidney disease.

RNA N6 -methyladenosine modifications and potential targeted therapeutic strategies in kidney disease.

Journal: British journal of pharmacology

Published: May 29, 2022

Inhibition of METTL3 attenuates renal injury and inflammation by alleviating TAB3 m6A modifications via IGF2BP2-dependent mechanisms.

Inhibition of METTL3 attenuates renal injury and inflammation by alleviating TAB3 m6A modifications via IGF2BP2-dependent mechanisms.

Journal: Science translational medicine

Published: April 13, 2022

Targeting TMEM88 as an Attractive Therapeutic Strategy in Malignant Tumors.

Targeting TMEM88 as an Attractive Therapeutic Strategy in Malignant Tumors.

Journal: Frontiers in oncology

Published: March 28, 2022

Showing 1-12 of 33

Last Updated: 09/26/2026